By Editor , 30 October 2026
Lead Image
60,000 White Flags to Fill the National Mall for Lung Cancer

WASHINGTON – October 29, 2026 -- LUNGevity Foundation's Every Breath Forward campaign will plant 60,000 white flags on the National Mall on November 1. During Lung Cancer Awareness Month, anyone can join through a home display, a volunteer shift, or a virtual dedication.

Each flag honors two lives lost to lung cancer

Each flag represents two of the more than 120,000 people who die from lung cancer in the United States every year. Volunteers will plant the flags, and a Survivor Rally will honor survivors and call for greater awareness and research.

By Editor , 29 October 2026
LUNGevity, Rising Tide Fund $620K EGFR Lung Cancer Resistance Trial

WASHINGTON – October 28, 2026 -- LUNGevity Foundation and the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) have awarded $620,000 to an early-phase clinical trial at The Ohio State University Comprehensive Cancer Center. The trial will test whether pairing two FDA-approved drugs can stop resistance to osimertinib in EGFR-positive non-small cell lung cancer (NSCLC).

By Editor , 29 October 2026
LUNGevity, RETpositive Award $340,000 to Fight RET Cancer Resistance

WASHINGTON – October 28, 2026 -- LUNGevity Foundation and patient advocacy group RETpositive have awarded a combined $340,000 to two research projects targeting drug resistance in RET-positive cancers, where tumors eventually outlast the two FDA-approved RET tyrosine kinase inhibitors (TKIs).

By Editor , 29 September 2026
LUNGevity Commits $2M to Two AI-Driven Lung Nodule Diagnostic Trials

Washington, D.C. – September 29, 2026 -- LUNGevity Foundation has committed $2 million to fund two three-year clinical research projects aimed at improving the diagnosis of indeterminate pulmonary nodules (IPNs), a condition affecting more than 1.5 million Americans annually after routine chest CT scans.